Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study.

Bridel, Claire; Beauverd, Yan; Samii, Kaveh; Lalive, Patrice H.
Neurol Neuroimmunol Neuroinflamm; 2(4): e123, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26140281